Artwork for podcast Pathfinders in Biopharma
How Biotech M&A is Redefining the Strategic Landscape
Episode 11 • 23rd June 2023 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:25:53

Share Episode

Shownotes

Given current macro and regulatory headwinds, determining the optimal time to sell a biotech company is a multifaceted decision that requires careful consideration of several key factors. Hear from industry veterans Ted Love, Marc de Garidel, and Abbas Kazimi who share their insights on a new era of M&A in a panel moderated by RBC Capital Markets Analysts Dr. Brian Abrahams, Dr. Luca Issi and Dr. Gregory Renza.

Follow

Links

Chapters

Video

More from YouTube